Evidence map›Paper›PMID 40443419›Full record

ArticleNIHR open research2025

Remote multicomponent rehabilitation compared to standard care for survivors of critical illness after hospital discharge (iRehab): a protocol for a randomised controlled assessor-blind clinical and cost-effectiveness trial.

Brenda O'Neill, Judy Martina Bradley, Bronwen Connolly, Julie Bruce, Martin Underwood, Ranjit Lall, Chen Ji, Jill Costley, Rachel Clarke, Paul Dark and 13 more

Abstract read
In one paragraph

Article in NIHR open research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Brenda O'NeillUlster University Institute of Nursing and Health Research, Belfast, Northern Ireland, UK.ORCID https://orcid.org/0000-0002-6471-1413
Judy Martina BradleyQueen's University Belfast Wellcome-Wolfson Institute for Experimental Medicine, Belfast, Northern Ireland, UK.
Bronwen ConnollyQueen's University Belfast Wellcome-Wolfson Institute for Experimental Medicine, Belfast, Northern Ireland, UK.ORCID https://orcid.org/0000-0002-5676-5497
Julie BruceUniversity of Warwick Warwick Clinical Trials Unit, Coventry, England, UK.ORCID https://orcid.org/0000-0002-8462-7999
Martin UnderwoodUniversity of Warwick Warwick Clinical Trials Unit, Coventry, England, UK.
Ranjit LallUniversity of Warwick Warwick Clinical Trials Unit, Coventry, England, UK.
Chen JiUniversity of Warwick Warwick Clinical Trials Unit, Coventry, England, UK.
Jill CostleyUlster University Institute of Nursing and Health Research, Belfast, Northern Ireland, UK.
Rachel ClarkeUniversity Hospitals Plymouth NHS Trust, Plymouth, England, UK.
Paul DarkThe University of Manchester Division of Infection Immunity and Respiratory Medicine, Manchester, England, UK.
Penelope FirshmanSurrey and Sussex Healthcare NHS Trust, Redhill, England, UK.
Nigel D HartGeneral Practitioner and Clinical Professor in General Practice, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, Northern Ireland, UK.
Annette HendersonUlster University Institute of Nursing and Health Research, Belfast, Northern Ireland, UK.
Katherine JonesUniversity of Warwick Warwick Clinical Trials Unit, Coventry, England, UK.ORCID https://orcid.org/0000-0003-0615-8442
Roger KenyonPatient advisory group and PPI representative on iRehab Trial Management Group, Preston, England, UK.ORCID https://orcid.org/0009-0004-6112-4557
Jason MadanUniversity of Warwick Warwick Clinical Trials Unit, Coventry, England, UK.
Gavin D PerkinsUniversity of Warwick Warwick Clinical Trials Unit, Coventry, England, UK.
Mariam RatnaUniversity of Warwick Warwick Clinical Trials Unit, Coventry, England, UK.
Kerry RaynesUniversity of Warwick Warwick Clinical Trials Unit, Coventry, England, UK.
Ella TerblanchePrincipal Critical Care Dietitian, Health Sciences University, Bournemouth, England, UK.
Rowena WilliamsUniversity of Warwick Warwick Clinical Trials Unit, Coventry, England, UK.
Mandana ZanganehUniversity of Warwick Warwick Clinical Trials Unit, Coventry, England, UK.ORCID https://orcid.org/0000-0003-3934-6044
Danny McAuleyQueen's University Belfast Wellcome-Wolfson Institute for Experimental Medicine, Belfast, Northern Ireland, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The consequences of critical illness can be substantial and multifactorial, encompassing physical deconditioning, mental health impairments, fatigue, and declines in health-related quality of life. We hypothesise that for people discharged after intensive care unit (ICU) for a critical illness, a six-week remote multicomponent rehabilitation intervention improves health-related quality of life, physical function, fatigue, mood, and other health-related outcomes after eight weeks, compared to standard care. Methods: This is a pragmatic, randomised controlled, open-label, assessor blind, multicentre, clinical and cost effectiveness trial with internal pilot and embedded process evaluation. Recruitment will take place in NHS hospitals across the UK. Adults (n=428: control n= 197; intervention: n=231) within 12 weeks of discharge from hospital following an ICU admission for critical illness, requiring mechanical ventilation ≥48hours will be recruited.The intervention is a six week multicomponent, structured, rehabilitation programme, delivered remotely by a trained intervention team. The intervention includes four components: weekly symptom management; targeted exercise; psychological support, and peer support and information. The control group will receive standard NHS care.The primary outcome is Health-related quality of life (HRQoL) at eight weeks post-randomisation measured using the EQ-5D-5L. Secondary outcomes are: HRQoL (six months), physical function, fatigue, illness perceptions anxiety and depression, healthcare resource use at eight weeks and six months and intervention acceptability. Conclusions: This trial will test a centrally delivered mulitcomponent rehabilitation intervention for survivors of critical illness, irrespective of geographic location or critical illness diagnosis. Trial registration: The trial is registered (04.07.2022) with the International Standard Randomised Controlled Trial Number (ISRCTN) Register ISRCTN11266403 https://doi.org/10.1186/ISRCTN11266403.

Indexed as

Critical illnessICUIndividualisedIntensive CareRecoveryRehabilitationRemote

Identifiers

PMID40443419
PMCPMC12120417

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.